MedPath

Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection

Completed
Conditions
Tuberculosis
Registration Number
NCT01601275
Lead Sponsor
Singapore General Hospital
Brief Summary

Prospective data collection of all patients with microbiologically proven mycobacteria tuberculosis infection treated at Singapore General Hospital.

Detailed Description

Tuberculosis currently infects one third of the world's population and is responsible for killing approximately 2 million individuals annually. This is a major public health concern worldwide, and there has been a huge impetus to implement strategies for better tuberculosis control.

The investigators have established a system to track all patients with microbiologically proven tuberculosis treated at Singapore General Hospital, with vigilant recording and reporting systems, from the first instance when patients were diagnosed to the time they have completed anti-tuberculosis chemotherapy. The investigators endeavour to use this system to improve patient care by adopting patient-supportive approaches that lead to high compliance rates and best possible outcomes of treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4600
Inclusion Criteria
  1. All patients with microbiologically proven mycobacteria tuberculosis infection treated at the Singapore General Hospital.
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Final outcomes of patients who have been diagnosed with microbiologically proven mycobacteria tuberculosis infection at Singapore General HospitalFrom diagnosis to final outcome
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Singapore General Hospital

πŸ‡ΈπŸ‡¬

Singapore, Singapore

Β© Copyright 2025. All Rights Reserved by MedPath